Gene · 4627
Papers4,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Temporal Assessment of Protein Stability in Dried Blood Spots. | J Proteome Res | 2024 | 38950347 | PubTator, text mining | PubMed |
| Detección de inclusiones citoplasmáticas gigantes en un paciente pediátrico con infecciones recurrentes: a propósito de un caso. | Adv Lab Med | 2024 | 38939200 | PubTator, text mining | PubMed |
| Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics. | Hamostaseologie | 2024 | 38925157 | PubTator, text mining | PubMed |
| Successful hematopoietic stem cell transplantation in MYH9-related congenital thrombocytopenia. | Pediatr Blood Cancer | 2024 | 38924207 | PubTator, text mining | PubMed |
| Correction: TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells. | Cancer Gene Ther | 2024 | 38918491 | PubTator, text mining | PubMed |
| A novel role for KIFC1-MYH9 interaction in triple-negative breast cancer aggressiveness and racial disparity. | Cell Commun Signal | 2024 | 38902769 | PubTator, text mining | PubMed |
| MafG/MYH9-LCN2 axis promotes liver fibrosis through inhibiting ferroptosis of hepatic stellate cells. | Cell Death Differ | 2024 | 38871948 | PubTator, text mining | PubMed |
| AMLdb: a comprehensive multi-omics platform to identify biomarkers and drug targets for acute myeloid leukemia. | Brief Funct Genomics | 2024 | 38864430 | PubTator, text mining | PubMed |
| OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway. | Mol Cancer | 2024 | 38849840 | PubTator, text mining | PubMed |
| Case Report: MYH9-related disease caused by Ala44Pro mutation in a child with a previous diagnosis of chronic immune thrombocytopenia. | Front Pediatr | 2024 | 38827217 | PubTator, text mining | PubMed |
| RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinoma. | Exp Mol Med | 2024 | 38825640 | PubTator, text mining | PubMed |
| Kidney Organoid Modeling of WT1 Mutations Reveals Key Regulatory Paths Underlying Podocyte Development. | Adv Sci (Weinh) | 2024 | 38810140 | PubTator, text mining | PubMed |
| Puerarin alleviates acrolein-induced atherosclerosis by activating the MYH9-mediated SIRT1/Nrf2 cascade to inhibit the activation of inflammasome. | Biotechnol Appl Biochem | 2024 | 38783542 | PubTator, text mining | PubMed |
| Cervical extracellular matrix hydrogel optimizes tumor heterogeneity of cervical squamous cell carcinoma organoids. | Sci Adv | 2024 | 38748808 | PubTator, text mining | PubMed |
| Quercetin promotes the proportion and maturation of NK cells by binding to MYH9 and improves cognitive functions in aged mice. | Immun Ageing | 2024 | 38730291 | PubTator, text mining | PubMed |
| TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells. | Cancer Gene Ther | 2024 | 38714850 | PubTator, text mining | PubMed |
| Epigenome-wide association study of lung cancer among never smokers in two prospective cohorts in Shanghai, China. | Thorax | 2024 | 38702190 | PubTator, text mining | PubMed |
| Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling. | Cell Mol Biol Lett | 2024 | 38698330 | PubTator, text mining | PubMed |
| Pseudorabies virus usurps non-muscle myosin heavy chain IIA to dampen viral DNA recognition by cGAS for antagonism of host antiviral innate immunity. | J Virol | 2024 | 38639486 | PubTator, text mining | PubMed |
| Characterization of Vestibular Phenotypes in Patients with Genetic Hearing Loss. | J Clin Med | 2024 | 38610765 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4627/papers?page=14